课题基金 / 基金详情

SIGNAL TRANSDUCTION BY IGM IN B LYMPHOCYTES

SIGNAL TRANSDUCTION BY IGM IN B LYMPHOCYTES
B 淋巴细胞中 IGM 的信号转导
批准号:
2413637
负责人:
Michel C Nussenzweig
金额:
$9.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-05-01 至 1998-04-30

项目摘要

项目成果

Michel C Nussenzweig的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Immunoglobulin is the B cell antigen receptor that is responsible for detecting foreign antigens and triggering a cascade of events whose end result is specific antibody production. Despite the central role of receptor immunoglobulin in the generation of immune responses, little is known about the mechanism by which this receptor produces a signal. Progress in understanding the mechanism of signaling by the immunoglobulin receptor has been hindered by two important features of this receptor. First the intracytoplasmic domain of the receptor is composed of three amino acids that offer no specific clues about the mechanism of receptor function. The second impediment to understanding receptor immunoglobulins is that they are associated with several other polypeptides on the cell surface to form a multi-subunit structure. Two of these receptor associated polypeptides MB-1, and B29 have been implicated in receptor assembly and cell surface transport, In addition, both MB-1 and B29 are rapidly phosphorylated upon receptor crosslinking, but the functional role of the IgM-associated proteins is poorly defined. We have recently succeeded in reconstituting receptor immunoglobulin function by transfecting cloned receptor components into T cells and macrophages, Although these experiments have defined the functional requirements for the production of an immunoglobulin antigen receptor in heterologous cells, they do not directly address the problem of antigen receptor function in B cells. The long range goal of the proposed research is to elucidate the molecular requirements for signal transduction by membrane anchored immunoglobulin in B lymphocytes. The working hypothesis is that B29, and MB1 are involved in signal transduction in B cells, and that the signaling apparatus of T and B cells is structurally homologous. The first part of the project will be to establish B cell lines that express transfected immunoglobulin receptors. For this purpose. we will use B cell lines that lack several receptor components. In the second part of the project we will examine the structural features of MB1 and B29 required to produce increased tyrosine phosphorylation, calcium mobilization, inositol turnover and IL-2 secretion in response to receptor crosslinking. These studies have potential implications for understanding how an antigenic stimulus triggers the generation of humoral immunity.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1084/jem.184.5.2025
发表时间: 1996-11-01
期刊: The Journal of experimental medicine
影响因子: --
作者: [Papavasiliou F, Jankovic M, Nussenzweig MC]
通讯作者: Nussenzweig MC
Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta.
免疫球蛋白的信号转导是通过 Ig α 和 Ig β 介导的。
DOI: 10.1084/jem.178.3.1049
发表时间: 1993
期刊: The Journal of experimental medicine
影响因子: --
作者: [Sanchez,M, Misulovin,Z, Burkhardt,AL, Mahajan,S, Costa,T, Franke,R, Bolen,JB, Nussenzweig,M]
通讯作者: Nussenzweig,M
Ig alpha and Ig beta are functionally homologous to the signaling proteins of the T-cell receptor.
Ig α 和 Ig β 在功能上与 T 细胞受体的信号蛋白同源。
DOI: 10.1128/mcb.14.2.1095-1103.1994
发表时间: 1994
期刊: Molecular and cellular biology
影响因子: 5.3
作者: [Burkhardt,AL, Costa,T, Misulovin,Z, Stealy,B, Bolen,JB, Nussenzweig,MC]
通讯作者: Nussenzweig,MC
DOI: 10.1084/jem.191.12.2113
发表时间: 2000-06-19
期刊: JOURNAL OF EXPERIMENTAL MEDICINE
影响因子: 15.3
作者: [Nagaoka, H, Gonzalez-Aseguinolaza, G, Tsuji, M, Nussenzweig, M C]
通讯作者: Nussenzweig, M C
The longevity and nature of the anti-SARS-CoV-2 cellular and humoral immune responses
  • 批准号:
    10841240
  • 项目类别:
  • 资助金额:
    $98.31万
  • 财政年份:
    2022
  • 负责人:
    Michel C Nussenzweig
  • 依托单位:
The longevity and nature of the anti-SARS-CoV-2 cellular and humoral immune responses
  • 批准号:
    10327992
  • 项目类别:
  • 资助金额:
    $145.45万
  • 财政年份:
    2022
  • 负责人:
    Michel C Nussenzweig
  • 依托单位:
Epitope-focused vaccine strategies against Zika virus
  • 批准号:
    10221136
  • 项目类别:
  • 资助金额:
    $81.67万
  • 财政年份:
    2020
  • 负责人:
    Michel C Nussenzweig
  • 依托单位:
Project 1
  • 批准号:
    10221139
  • 项目类别:
  • 资助金额:
    $81.67万
  • 财政年份:
    2020
  • 负责人:
    Michel C Nussenzweig
  • 依托单位:
海外基金